Cargando…

Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC

INTRODUCTION: In advanced-stage NSCLC, tumor proportion score (TPS) is typically used to predict the efficacy of immune checkpoint inhibitors (ICIs). Nevertheless, in other cancer types, the combined positive score (CPS), which covers programmed death-ligand 1 (PD-L1) expression on both tumor and su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ulas, Ezgi B., Hashemi, Sayed M.S., Houda, Ilias, Kaynak, Adem, Veltman, Joris D., Fransen, Marieke F., Radonic, Teodora, Bahce, Idris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480627/ https://www.ncbi.nlm.nih.gov/pubmed/37681219 http://dx.doi.org/10.1016/j.jtocrr.2023.100532

Ejemplares similares

Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better?
por: Ulas, Ezgi B., et al.
Publicado: (2023)

Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial
por: Dickhoff, Chris, et al.
Publicado: (2020)

Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients
por: Bach, Sander, et al.
Publicado: (2021)

Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies
por: Kapil, Ansh, et al.
Publicado: (2018)

The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis
por: Ronden, Merle I., et al.
Publicado: (2021)

Tumor Atelectasis Gives Rise to a Solid Appearance in Pulmonary Adenocarcinomas on High-Resolution Computed Tomography
por: Ambrosi, Francesca, et al.
Publicado: (2020)

Association of PD‐L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR ‐mutated NSCLC
por: Hamakawa, Yusuke, et al.
Publicado: (2023)

Radiolabeled EGFR TKI as predictive imaging biomarkers in NSCLC patients – an overview
por: Van De Stadt, Eveline, et al.
Publicado: (2022)

Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system
por: Prelaj, Arsela, et al.
Publicado: (2020)

Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy
por: van Duijvenvoorde, Maurice, et al.
Publicado: (2022)

Compact portable multiphoton microscopy reveals histopathological hallmarks of unprocessed lung tumor tissue in real time
por: van Huizen, Laura M. G., et al.
Publicado: (2020)

Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study
por: Dimitrakopoulos, Foteinos-Ioannis, et al.
Publicado: (2022)

Proportional Distribution of Patient Satisfaction Scores by Clinical Service: The PRIME Model
por: Leonard, Michael S, et al.
Publicado: (2015)

The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy
por: De Giglio, Andrea, et al.
Publicado: (2022)

An approach to scoring cursorial limb proportions in carnivorous dinosaurs and an attempt to account for allometry
por: Persons IV, W. Scott, et al.
Publicado: (2016)

Trend-constrained corrected score for proportional hazards model with covariate measurement error
por: Zhu, Ming, et al.
Publicado: (2015)

From the Spinopelvic Parameters to Global Alignment and Proportion Scores in Adult Spinal Deformity
por: Cho, Yongjae, et al.
Publicado: (2023)

The Landscape of Immunotherapy Resistance in NSCLC
por: Frisone, Daniele, et al.
Publicado: (2022)

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016)

Focal (18)F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers
por: Smesseim, Illaa, et al.
Publicado: (2023)

False positivity in break apart fluorescence in-situ hybridization due to polyploidy
por: van Gulik, Anna Lena, et al.
Publicado: (2023)

Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC
por: Joosten, Pieter J.M., et al.
Publicado: (2021)

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab
por: Seban, Romain-David, et al.
Publicado: (2020)

Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
por: Mercier, Anaïs, et al.
Publicado: (2023)

Prediction of prognosis and outcome of patients with pulmonary embolism in the emergency department using early warning scores and qSOFA score
por: Yolcu, Sadiye, et al.
Publicado: (2022)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Immunotherapy and NSCLC: The Long and Winding Road
por: Rossi, Antonio
Publicado: (2020)

Immunotherapy in NSCLC Patients with Brain Metastases
por: Buriolla, Silvia, et al.
Publicado: (2022)

Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
por: Zarogoulidis, Paul, et al.
Publicado: (2022)

Erratum: The landscape of immunotherapy resistance in NSCLC
Publicado: (2023)

PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors
por: Dimitrakopoulos, Foteinos-Ioannis, et al.
Publicado: (2020)

Modified Global Alignment and Proportion Scoring With Body Mass Index and Bone Mineral Density Analysis in Global Alignment and Proportion Score of Each 3 Categories for Predicting Mechanical Complications After Adult Spinal Deformity Surgery
por: Noh, Sung Hyun, et al.
Publicado: (2021)

The Impact of Global Alignment and Proportion Score and Bracing on Proximal Junctional Kyphosis in Adult Spinal Deformity
por: Lord, Elizabeth L., et al.
Publicado: (2021)

Commentary on “Modified Global Alignment and Proportion Scoring With Body Mass Index and Bone Mineral Density Analysis in Global Alignment and Proportion Score of Each 3 Categories for Predicting Mechanical Complications After Adult Spinal Deformity Surgery”
por: Chou, Dean
Publicado: (2021)

Central Venous Catheter Insertion: A Scoring System for Evaluation of Both the Procedure and the Operator (CVCI Score/Gaber Score)
por: Gaber, Sayed, et al.
Publicado: (2020)

Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate
por: Witte, Hanno M., et al.
Publicado: (2020)

Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
por: Yi, Chengxiang, et al.
Publicado: (2019)

Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
por: Zarogoulidis, Paul, et al.
Publicado: (2020)

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
por: Fitzpatrick, Orla, et al.
Publicado: (2021)

Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC
por: Roller, John F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_odkkl9r5tog3bhf5dt61q5bpga